This evidence has driven in the last years an important ongoing area of investigation devoted to identifying tumors that are particularly sensitive to G6PD inhibition, unveiling an urgent need to explore the impact of tumor microenvironment nutrients on G6PD upregulation in cancer. This evidence concerns the gene G6PD and neoplasm.